Publication details
Activating mutations in the epidermal growth factor receptor gene in non-small cell lung cancer fixed tissue: Analysis and one center experience
| Authors | |
|---|---|
| Year of publication | 2012 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Attached files | |
| Description | Targeted treatment of patients with non small cell lung cancer (NSCLC) with tyrosine kinase inhibitors (TKI) of epidermal growth factor receptor gene (EGFR) is conditioned by EGFR mutation status assessment. Tyrosine kinase domains of exons 18–21 of gene EGFR was analysed in non selected NSCLC patients. |